The new 5-year plan aims to improve cancer care in the United Kingdom to "world class" levels and promises treatment within 31 days for every cancer patient. Medscape Medical News
In this Expert Interview, Dr. Andrew D. Seidman critically appraises the latest data, addresses the controversies, and opines about adjuvant systemic therapy for breast cancer. Medscape Hematology-Oncology
Bevacizumab has shown significant single-agent activity in relapsed ovarian cancer in 2 phase 2 trials, prompting further studies of this disease. Medscape Medical News
An experimental peptide vaccine produced an immunologic response in more than half of study participants and was associated with longer event-free survival and periods of remission. Medscape Medical News
A novel product mobilizes stem cells quickly and increases the yield, making stem cell transplantation a viable option for more patients. Medscape Medical News
